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Peripheral blood T-cell s ubpopulations and B-cell 
numbe r s from 25 patients with uncomplicated psoriasis 
and 22 patie nts with psoriatic arthritis were compared 
with those of 24 age- and sex-matched healthy volun-
teers and 11 patients with rad:iolob>ically defined erosive 
osteoarthritis. The numbers of early and late rosettes 
w e r e found to be reduced in patients with psoriasis, with 
and without arthritis, while the total T-cell population 
(measure d by aminoethylthiouronium bromide-rosettes) 
was found to b e normal. There was no diffe r ence in the 
number of B cells between psoriatic patients and con-
trols. Dose-response studies of mitogen s timulation with 
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Abbreviations: 
AET: aminoelhylthiouronium bromide 
Con-A: concanavalin A 
FC. : fetal calf serum 
HBSS: Hanks' balanced salt solu tion 
lg: immunoglobulin 
NSAID: nonsteroidal anti-in!lammatory drugs 
PBM: peripheral blood mononuclear cells 
PBS: phosphate-buffered saline 
PHA: phylohemagglu tinin-P 
PWM: pokeweed mitogen 
SHBC: sheep reel blood cell (s) 
UVll: ullraviolel radiation 
phytohemagglutinin and concanavalin A revealed gen-
erally highe r proliferative responses in the psoriatic pa-
t ients only at supraoptimal concentrations. The poke-
w eed mitogen response, however, was reduced in pa-
tients with c utaneou s psoriasis and increased in patients 
with psoriatic arthritis. These studies further support 
the concept of an immunologic imbalance in lymphocyte 
populations from patients with psoriasis and psoriatic 
arthritis. 
It has been proposed t hat immunologic a bnormali t ies m ay 
play a role in t h e pathogenesis of psoriasis a nd psoriat ic a r t lu·itis 
[1. ,2]. Evidence to support this t heory has accumulated in the 
past d ecade [3-16]. E levated levels of immunoglobulins have 
been found in the sera of patien ts with pso rias is and psoriatic 
a rth.ri t is [3,4] a nd a nti-immunoglobulin activi ty has been dem-
onstrated in bot h sera [ 4-6] a nd tissues [7-9] of psoriatic 
patients . These findin gs have suggested a hyperactive B-cell 
r esponse. Studies of cell-m ediated immune response in psoriatic 
pati ents have been contra dictory. T h e r esults of mitogen stim-
ulation studies ha ve varied and include r eports of increased, 
dec reased , and norma l responses [10- 17]. ImpaiTed suppressor 
T -cell activity has recen tly been demonstrated in both cu ta-
neo us psori asis [18,19] a nd psoria t ic a rthri t is [20]. T-cell num-
bers reported in the li terature have varied from low [12,13,-
17,2 1-25] to normal [26,27]. 
The present investigation was carri ed out in order to cla ri fy 
some of the contra dictory results described in patients with 
psorias is and psoriat ic a rthritis. We have enumerated periph-
eral blood T-cell subpopulations and B-cell numbers in patien ts 
April1983 ABERRATIONS IN T- CELL SUBSETS IN PSORIASIS AND PSORIATIC ARTHRITIS 287 
with psoriasis and psoria t ic artlu-itis a nd compared t hem to 
patients with e rosive osteorutlu-itis and normal con tro ls . An 
imbalance in T-ce!J subsets was demonstrated in patients wi t h % 
uncomplicated psoriasis a nd psoria tic arthritis. Dose-response 
st udi es of mitogen s timulat ion in these pa ti ents furth er sup- 50 
ported the concept of an immunologic imbalance in these 
disorders. 
A B 
M ATERIALS AND METHODS 
Patient Selection 
T went y- fi ve pa l ien ts wi th psorias is, uncomplicated by arthri tis, and 








and l'tesearch Cente r (PEI{C) and the psoriatic a rt hri t is c linic at 30 
Women';; College Hospita l, T oronto, were s tudied (Table I). Although 
topical med ications, ul! rav iole t radia tion (UVR) , a nd nons te roida l anti -












.. ~ taken o ra l steroid ;;, ret ino ids, methotrexate, P UVA, gold, chloroquine. ZO 
or penicillamine prior to the s tudy. Clinical assessmen t:;; were performed I 
0 I I • 8 by a dermato logi:;t and a rheuma tologis t according to a standard 
pro toco l. Percent skin involvement, number of ''active ly' ' infla med 
join ts (tenderness, s tress pa in , effus ions), and a rticular index were 
00 
1 0 
recorded Cor each pa t ient. 10 •• .; 
• y 
Contro l., 
Twen t.v- four age- a nd sex-ma tched healthy volu nteers (hospi ta l per-
sonn el) se rved as " norma l controls" and were stud ied during Lhe same 
Lime pe riod. An addi t iona l group o r 11 pat ien ts with radiologica lly 
defin ed e rosive os leoa r! hritis se rved as disease controls . All t hese 
pa tien ts were la king NSAID. All patients a nd contro ls ga ve an informed 
consent. 
Cell Separation 
Periph era l b lood mononucl ear .cell s (l'BM) were isolated by hy-
paqu c-F ico ll gradient centrifuga tion [28l Th e sepa rated cells were 
washed twice with a lpha medium (National Cancer Institute, T oronto) 
con! a inin g- 50 U/ ml penicill in , .~0 /lg/ml slreptom.vc in, and 2 mM/ ml L-
g lutanline. 
E -R o.-;ett es 
E-rose t tes were pe rformed b.v resuspending PBM in phospha te-
buffe red saline (PBS ), pH 7.4, in a concen t ration of 3 X tOn ce lls/ mi. 
One hundred microlite rs or ce ll suspension were add ed to 100 ~d of a 1% 
sheep reel blood cell (SHBC) suspens ion and incuba ted at 37°C for 15 
min. Ea rly rose t tes were enumera ted immedia tely fo llowing centrifu-
ga tion of the ce ll mix! ure at 1000 rpm for 5 min a t mom tempera! ure. 
Late mseUes were prepa red in a s imi la r fashion except tha t the result-
ant pelle t was incuba ted ove rnigh t a t 4°C and resuspended prior Lo 
coun ting. For de tection of t he tota l E- roseLLing popu la tion , 1 vol or 5% 
SHBC was pre incuba tcd for 20 min a ! 07°C with 4 vol of 0.14 M 
aminoethylthiouronium bromide (AET) (S igma, (. Louis, Missouri) , 
and washed with PB. prior to the ir add it ion to t he PBM suspension. 
The l'BM-SRBC mixture was centrifuged at 2000 rpm for 1 min and 
TARL to: I. Clinical data of patients with' uncomplicated psoriasis 
and psoriatic arthrit is 
Number or patients 
Male/female 
Mean age (ra nge) 
Mean disease duration in years 
(range): 
Sk in 
Jo in ts 
Mean percent skin in volvement 
(range ) 
Mea n number o f "act ive'' joint s 
(± SE) 
Mean Lansbury Articula r Ind ex 
(± SE) 
T herapy (number of pat ients ) 
N il 
UVJ 
Topica l s tero id 
NSAJD 
Pso ri a.s i ~ 
25 
20/ 5 
. 4 1 (21-74) 




Psori at. i<.: a rLhrit is 
22 
9/ 13 
52 (24- 76) 
11 .0 (2.5-55) 
7.0 (0.1-30) 
IG (0.5-75 ) 
12 ± 2 







ARTHR I Tl S 
Ft G I. Ea rly E-rosettes in pa tients with psoriatic art hJ·it is (A) and 
uncomplicated pso riasis (B). In each pa ne l, x depicts the mean response 
and the error bars represent ± SE. Patients are represented by (e) 
a nd age- and sex-matched hea lthy con trols by 0 . 
t he pell et immediate ly resuspended for enumeration of t he msettes. In 
all the roset Le assays, the pe lle t was gently resuspend ed a nd the 
suspension transferred to a hemocytometer cham bet· for coun ting. T wo 
hundred ce lls were coun ted and i he pro pori ion of PB M binding 3 or 
more SHBC was detenninecl. Immunoglobulin (!g) -bearing lymph o-
cytes were de tec ted b.v us ing techniqu es of aMi-immunoglobulin flu o-
rescent st ain ing. Brien.v PBM. in a concentration of 4 x 10'; ce lls/ ml 
were resuspended in Ha nks' ba lanced sa lt solution (HBSS) and 5CJ; 
feta l ca lf' se rum (FCS). Fifty microli te rs of I he cell suspension was 
incubated with 50 11l of fl eurescein iso thiocyanate (FITC)-conjugated 
(Fab ' )" goat an tihuman Ig (Cappel La borator ies, T oronto, Onta rio) for 
30 min at 4°C. Following centrifuga tion a t 500 rpm for 5 min a t 4°C the 
supernatant was removed and t he cells washed tw ice with HE SS and 
5% FCS mixed with 50% glycerine. The suspens ion was t ransferred to 
s lides incuba ted fo r 10 min in !.he cold and read with a Leit z-Ort holux 
microscope with flu orescence ve rtical and phase contrast illumina tors. 
Two hundred ce lls were counted and the percen tage of nuorescing ce lls 
determined. 
Mito{fen -Induced Lymphocyte Transformation 
PBM were resuspended in a lpha medium conta ining IO'ii· pooled 
human AB serum. Triplica te 200-111 cultures each cont a ining 5 X JOH 
ce lls were se t up in fl a t-bol! omed Linbro microlite r we lls. Fi fty micro-
li ters of mitogens was added to each cul t ure in va rying concent.rat ions 
as fo llows: phy to hemagglutini n-P (PI--TA) (Welcome, England ) 0.6. 2.25, 
4.5, 18, 180 ~tg/cu l tu re, concanavalin A (Con-A ) (Calbiochem. La Jo lla. 
Ca lifornia) 0.5, 1.0 and 2.0, 40, 80 /lg/ cult ure, and pokeweed mit ogen 
PWM (GIBCO Grand Island , New York ) 0.1, 0.5, I , 20 dilution x 10 ;'/ 
cul ture. J'BM incuba ted with PHA a nd Con-A were cul tured fo r 5 days 
and those incubated with PWM were cultured for 7 days. Tritia t~d 
thymidine (0.2 ,,Ci/ culturc, sp ac! 18.4 Ci/ mmol) was added 4 h prior 
to harvest.. Trit ia ted thym idine incorporation was dete rmined by liquid 
sc intillation counting. S ta tis t ica l a na lys is of the di fferences between 
groups was determined by Lh c S tudent t-test a nd t.he Mann-Whitney 
rank sum test. 
RES ULTS 
Lymphocyte Su bpopu La I ions 
Analysis of ea rly rosettes in 25 patients with uncomplicated 
psoriasis a nd in 11 patients with psoriatic a rthritis revea led 
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TABLE Il. Lymphocyte nwrhers (rom patients with u.ncomplicated psoriasis, psoriatic arthritis, and osteoarthritis and healthy control:; 
Lymphocy te marke r 




Ig-bearing cells (B) 
Numbers refer to mean values± SE. 
NA = not assessed . 
Psori atic arthritis 
20.0 ± 3.0" 
56.6 ± 2.01' 
82.3 ± 1.8 
22.3 ± 2.9" 
9.2 ± 1.5 
" Difference between patient group and controls at p < 0.05. 
" Difference between patient group and controls at p < 0.001. 
,. Diffe rence between patient group and contro ls at p < 0.005. 
significantly lower percentages of early rosettes in t he psoriatic 
patients relative to the age- and sex-matched normal controls 
(F ig 1, Table II). S imila rly, late rosettes were significantly lower 
in both patient groups (25 patients with uncomplicated psoriasis 
and 22 patients wit h psoriatic arthr it is) than t hose of healthy 
controls a nd of patients with erosive osteoarthrit is (Fig 2, Table 
II) . T here were no s ignificant differences in the total rosette-
form ing cell pop ulations, as measured by AET-rosettes, among 
the groups of patients with uncomplicated psoriasis, psoriatic 
a rthritis, osteoarthri t is, and healt hy controls (Ta ble II). In 
order to further delineate differences in E-msette formation 
between patients and controls, the number ofT cells forming 
rosettes with AET-treated SRBC but negative in the late E-
rosette assay (AET4 ;E- ) was calcu lated for each group (Table 
II). The mean number of AET+ ;E- T cells from patients with 
uncomplicated psoriasis and with psoriatic arthritis were sig-
nificantly higher than those of patients wit h erosive osteoar-
thritis and of normal controls. The number of Ig-bearing cells 
was not statistically different in the 4 groups of patients (Table 
II). 
Lymphoproliferative Studies 
Mitogen dose-response studies were performed on lympho-
cytes from 10 patients with uncomplicated psoriasis a nd 10 
% A B c 
80 0 
0 0 
70 0 8 0 0 
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PSOR IATI C NORMAL PSORIASI S NORMAL OS TEO - NORMAL 
ARTHR ITI S ARTHR ITIS 
F I G 2. Late E-rosettes in pa t ients with psoriatic a rthri tis (A) , un-
complicated psoriasis (B), and erosive ostcoarthri ti · (C) .ln each panel, 
x depicts the mean response and the error bars represent ± 1 SE. 
Patients are represented by e and age- a nd sex- matched healthy 
contro ls by 0 . 
Psoriasis OA Normals 
20.5 ± 2.0" NA 25.5 ± 1.8 
56.8 ± 2.1 " 64.8 ± 3.0 63.2 ± 1.1 
81.0 ± 1.0 82.4 ± 3.0 82.0 ± 1.4 
24.7 ± 2.3'" 16.8 ± 3.5 16.6 ± 2.4 
9.1 ± 1.3 8.0 ± 1.6 10.1 + 1.4 
patie nts with psoriatic arthri t is and compared to those of age-
and sex-matched healthy controls. As shown in Fig 3, t here was 
no s ignificant difference in peak responses to PHA between 
patients with psoriasis and norma l contro ls. However, at high 
concentrations of PHA, the r esponse of lymphocytes from 
patients with psoriasis was significantly higher tha n t hat of 
normal controls ( p < 0.05). S imilar results were demonstrated 
with Con-A, although the difference was not statistically sig-
nifi cant. The dose-response curve to PWM of patients with 
psoriasis was similar to normal controls but the response was 
sign ificantly lower (p < 0.05) in a ll but the lowest concentration. 
Lymphocytes from patients wi th psoriat ic arthri t is (Fig 4) 
behaved similarly, showing significantly higher proliferation 
only at high concen tration of PHA and Con-A. However, the 
peak lymphocyte response to PWM of lymp hocytes fTom pa-
tients with psoriatic a rthritis was significant ly higher tha n that 














0.6 2.25 4.5 18 180 
ug/culture 
CON A PWM 
0.5 10 20 40 80 0.1 0.5 20 
1-lQ/cu lture dilutiOn X 1 Q• lfCU1!ure 
FIG 3. Mitogen stimulation studies in patients with psorias is (e) 
and age- a nd sex-matched healthy controls (0 ). Each dol represents 


















' ' v 
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0.6 2.25 4 .5 18 180 
IJg/culture 
CONA PWM 
0.5 10 20 40 80 0 .1 0 .5 1 20 
ug/cuJture di lution x 1Q•lfcu lture 
FIG 4. Mitogen stimulation studies in psoriatic a rthritis (e) com-
pared to age- and sex-matched hea lthy cont rols (0 ). Each dot repre-
sents the mean response of 10 individuals. The error ba.rs represent ± 
I SE. 
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There was no correlation between the extent of skin disease, 
measuTed by percent skin involvement, a nd percent r osettes or 
lymphocyte reactivity to mitogens of patients wit h psoriasis. 
H owever, patien ts with psoriatic arthri t is wi t h early rosettes of 
less than 25% had significant ly higher join t coun ts tha n t hose 
with normal (> 25%) early rosette coun ts (p < 0.001) . There 
was no r ela tionship between roset te numbers a nd the use of 
either U VR therapy or topical steroid therapy . 
DISCUSSION 
Immunologic abnormalities a re considered importa nt factors 
in the pathogenesis of psoriasis [1 ,2]. A cen tral r ole for T -cell 
dysfunction h as been sugge ted [1,2,10-24]. Reduced numbers 
of E-rosette-forming cells in psoriasis have been r epor ted by 
several investigators [12,13,20-24]. T he present study has dem -
onstrated reduced levels of early and late E-rosettes in patients 
with cutaneous psoriasis and with psoriatic ar thri t is, as com-
paTed to normal contr ols and to patients with erosive osteoar-
tru·it is. H owever, AET-rosettes, which measure t he total T -cell 
population, were normal. These r esul ts did not correlate wi th 
the use of UVR or topical steroid thera py. P a ti ents wi th os-
teoar thri t is were also taking N SAID and the i1· r esul ts were 
norma l. We t herefore feel that our resul ts do not represen t d1·ug 
effect. 
Eru·Iy rosettes are cons idered to be a subpopulation of T cells 
wi th high a ffini ty for SRBC [29- 31]. These cells m·e though t to 
serve as effecto r cells a nd may r efl ect more closely the in vivo 
immune response pattern [30,31]. D epressed levels of early 
rosettes have been shown in some patients wi th cer tai n malig-
nant condi t ions a nd immunode.ficiency states [29,30]. Al though 
the diminu tion of early rosettes in patients wi t h psoriasis a nd 
psoria tic ar thr it is did not correlate wi th the extent of skin 
disease, low roset te numbers correlated with more severe joint 
disease. 
Our findin gs of low late rosette-forming cells confim1 previous 
reports of low T cells. Guilhou a nd coworkers [12,13], C01·mane 
et al [21], Glinski et a l [22], and Sany a nd Clot [17] have all 
observed decreases in late rosette-forming cells in patients with 
psoriasis and psoriatic ar thri t is. We, like Glinski et al [22], 
fo und no corre lation between the extent of skin disease and T-
cell levels. 
It has been suggested that the decrease in T cells noted in 
patients with pso riasis may refl ect a reduction in or the a bsence 
of clones of suppressor cells [1]. We and others have shown that 
the re is a suppressor cell defect in both psoriasis and psoriatic 
arthri t is [18-20]. M ore recently, we have confirmed an imbal-
ance in the immunoregula tory T-cell populations in patients 
with psoriatic a rthri t is [32]. Using orthoclone monoclonal ant i-
bodies, we have shown that patients wi th psoria tic rutru·it is had 
decreased levels of OKT 3 (T cells), a nd OKT 8 (suppressor-
cytotox ic cells ). An increase in t he OKT 4 to OK T 8 ratio was 
demonstrated , suppor ting our content ion that there is an im-
balance in T-cell subpopulations. 
In the present study, t he total T-cell population as measured 
by AE T-rosettes was found to be normal in th e face of reduced 
early a nd late E-rosettes. Such ·differences between AET-ro-
settes and late E -rosettes have been previously described in a 
variety of unrelated condi t ions [33]. This discrepa ncy may be 
re lated to an actual al teration in lymphocyte subpopulations, 
or it may suggest the presence of an immature population of T 
cells. It has been shown t hat the incubation of mononuclear 
cells from patients wi th rheumatic diseases wi th thymosin led 
to an increase in E-rosette-forming cell numbers [34,35]. It has 
been suggested that thy mosin effect proba bly represents stim-
ulation ofT-cell maturation from precursor cells [33- 35]. It is 
possible that t he differ ences observed in the present study 
refl ect a n increased number of immature T cells in the periph-
eral blood of patients wi th psoriasis a nd psoriatic artlui t is. 
Other possibilities, however, could accoun t for t he differences 
between AET- and E-roset te-formin g cell numbers . There may 
be a reduction in the affini ty and/or numbers of SRBC recep-
tors as a consequence of interfering humor al substances. Indeed, 
a ntily mphocyte a nt ibodies have been shown to redu ce the 
number of E-rosette-forming cells detected in cer tain disease 
states [36,37]. Gelfand et al [33] have shown that T -cell antisera 
can inhibi t E -rosette formation, but that a much higher con-
centration of antiserum was req uired to inhibi t AET-rosettes. 
Al though such ant ilymphocyte a nt ibodies have not been re-
ported in psoriasis and psoriatic arthri tis, the presence of a nti-
stra tum corneum antibodies a nd an a nt ibody to basal cell nuclei 
have been demonstrated in t he sera and lymphoid cell mem-
branes in patien ts wi th psoriasis [2]. Immune complexes have 
a lso been demonstrated in t he sera of patients with both pso-
riasis a nd psoriatic arthTitis [27), a nd t hese too could interfere 
with SRBC receptors. W hether the red uced numbers of cells 
with receptors for late and eru·ly E-rosette-forming cells repre-
sent an aberration in recep tor interaction or a deletion in 
lymphocyte subpopulations remains to be determined. Studies 
are current ly under way in our laboratory to discern the func-
t ional characteristics of t he AET+ IE- cell population in relation 
to immune regulatory activity . 
Reported data concerning ly mphoproliferative responses to 
mi togens in uncomplicated psoriasis a nd in psoriatic ar thritis 
have been conflicting. Whereas Levant ine a nd B rostoff [11) 
reported a decreased response to PHA in patients with psoriasis, 
both Guilhou et al [12) a nd Clot a nd Guilhou [13] reported 
normal responses. In psoriatic artlui t is, Sany and Clot [17] 
demonstrated a normal lym phocyte response to PHA, while 
Espinoza et al (15] reported a decreased response in such 
patients. Frobel eta) [10] observed that, at h igh concentrations 
of PHA, lymphocytes fro m 11 patients with psoriatic arthr it is 
were hyperreactive compared to normal con trols. T he present 
study may provide an expla nation for the discrepa ncies of the 
previous repor ts. We found that, at high concen trations of 
mi togen, ly mphocytes from patien ts wi th eit her uncom plicated 
pso riasis or pso riatic ar t hri t is were hyperreactive, whereas at 
the lower (more op timal) concentrations, th e r esponses were 
either normal or slightly reduced . T he response of lymphocytes 
fTom pa tients with psoriasis to Con-A has been obser ved to be 
low by several investigators [12,13,15] and normal by others 
[16,19]. We fo und that, with high concen trations of Con-A, as 
with PHA, lymphocytes fr om psoriatic patients were h yper-
reactive. P WM responsiveness was reported to be low in pa-
t ients wi th cutaneous psoriasis by Guilhou and coworkers 
[12,13). We found similar resul ts in our patients with psoriasis. 
The dose-response curve of lymphocytes of patients with pso-
riatic a rthri t is to PWM was parallel to the normal cm ve, bu t 
t heir responses were higher at each concentration . T his latter 
resul t is in disagreement with previous repor ts of low [15] or 
norm al [17] r esponses to P WM in these patients. The abnor-
mali t ies in lymphocyte responsiveness to mitogens observed in 
patients wi t h psoriasis and psoriatic arthr it is and the close-
response kinetics may resul t from the abnormali ties in T-cell 
su bpopulations described, and may indeed reflect the presence 
of immature cells which require higher dose of mitogen for 
response. 
In summary, we have demonstrated abnormali ties in T-cell 
subpopula tions in patients wi th uncompli cated psoriasis a nd 
psoriatic ar thri t is. T hese abnormalt ies may lead to abnormali-
t ies in T -ceU function. This supports the concept t hat immu-
nologic a bnormali ties may be relevant in th e pathogenesis of 
both psoriasis a nd psoriatic a r thrit is. 
The aut hors wish to acknowledge t.he helpfu l comments of Dr. 
Abraham Shore, the technical assistance of Mrs. Lorraine Poplonski, 
and Lhe secretarial assistance of Miss Nancy heridan. 
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Three Bill R eed International Travelling Fellowships will be awarded this year as follows: 
The winner of the Poster Session a t the annual meeting of the European Society for D erma tological R esearch will 
be awarded $800.00 to help support a trip to a ttend the annual meeting of the American Academy of Dermatology. 
The winner of the Stelwagon Prize for the best paper presented at the Residents' Forum a t the annual American 
Academy of D ermatology meeting will receive an $800.00 award to support a trip to Europe where the awardee will 
present a paper at the annual meeting of the British Associa tion of Dermatologists in England. Further travel to 
European centers can also be arranged. 
An award of $800.00 will be given to an academically oriented dermatologist in the private practice of clinical 
dermatology, who has been out of training no more than five yea1·s. It is meant to support travel for educational 
purposes and to broaden contacts with dermatologic investigators. Applicants should send ·their cw-riculum vitae and 
a covering letter, indicating how he/she plans to spend the award funds, to the Chairman of the Committee on 
International Affairs of the A.A.D . at the Academy office, 1567 Ma ple Avenue, Evanston, Illinois 60201. The deadline 
for submission is September 1, 1983. Supporting let ter from a broad relevant to the planned travel are desira ble. The 
award will be announced in December and will be based on the originality and productivity of t he applicant as well 
as the meritoriousness of the travel pla ns for continued clinical investigation. 
